You are here

  • Home
  • Archive
  • Volume 78, Issue 6
  • Comparisons of hepatitis C viral replication in patients with rheumatoid arthritis receiving tocilizumab, abatacept and tofacitinib therapy

Article metrics

Article menu
Download PDFPDF
Letter
Comparisons of hepatitis C viral replication in patients with rheumatoid arthritis receiving tocilizumab, abatacept and tofacitinib therapy

 

Online download statistics by month:

Online download statistics by month: January 2019 to March 2024

AbstractFullPdf
Jan 20191936191130
Feb 201911434836
Mar 201911203028
Apr 201911103524
May 201910136556
Jun 20192945238
Jul 20192123428
Aug 20191102315
Sep 20191362117
Oct 20191181916
Nov 20196577
Dec 201998910
Jan 20201801710
Feb 20201552511
Mar 20201963224
Apr 20201971845
May 2020141618
Jun 20201022019
Jul 20201381220
Aug 20201441421
Sep 20201121512
Oct 20201301114
Nov 2020105515
Dec 202010027
Jan 20211221227
Feb 20211741113
Mar 20211341419
Apr 2021871519
May 2021421210
Jun 202118910
Jul 2021221415
Aug 202118813
Sep 2021491215
Oct 20211411115
Nov 202111288
Dec 2021337129
Jan 2022140169
Feb 202213035
Mar 20226167
Apr 20229221
May 20228743
Jun 2022198155
Jul 202290810
Aug 202215484
Sep 202212678
Oct 2022174915
Nov 202278133
Dec 2022221113
Jan 2023104118
Feb 20237410
Mar 20235652
Apr 20232000
May 20232930
Jun 20231900
Jul 20233091
Aug 20237935
Sep 20236224
Oct 20233787
Nov 20234722
Dec 20233227
Jan 20245115
Feb 20242941
Mar 20243363
Total125641008912